Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma

ObjectiveThe Ki-67 index is used to evaluate cell proliferation activity, which is related to tumor progression, metastasis, and prognosis. We aimed to explore the prognostic value of Ki-67 index in endometrial stromal sarcoma and to explore the optimal cut-off value of Ki-67 index for predicting re...

Full description

Bibliographic Details
Main Authors: Yu Meng, Quan Quan, Fenfen Zhang, Yao Liu, Siling Ren, Xiaoling Mu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.823505/full
_version_ 1818954820577394688
author Yu Meng
Quan Quan
Fenfen Zhang
Yao Liu
Siling Ren
Xiaoling Mu
author_facet Yu Meng
Quan Quan
Fenfen Zhang
Yao Liu
Siling Ren
Xiaoling Mu
author_sort Yu Meng
collection DOAJ
description ObjectiveThe Ki-67 index is used to evaluate cell proliferation activity, which is related to tumor progression, metastasis, and prognosis. We aimed to explore the prognostic value of Ki-67 index in endometrial stromal sarcoma and to explore the optimal cut-off value of Ki-67 index for predicting recurrent endometrial stromal sarcoma.MethodsA total of 82 patients with endometrial stromal sarcoma who were treated in our hospital were collected. Clinicopathological data of these patients were retrospectively analyzed. Ki-67 index was detected by the immunohistochemical method. Receiver operating characteristic curve and the Youden index were performed to determine the optimal cut-off value of Ki-67 index for predicting recurrent endometrial stromal sarcoma. The Cox regression was performed to analyze risk factors affecting prognosis of endometrial stromal sarcoma. The Kaplan–Meier method and Log-rank test were performed to analyze the survival of patients.ResultsThe optimal cut-off value of Ki-67 index for predicting recurrent endometrial stromal sarcoma was 35%. The results of univariate analysis showed that high Ki-67 index (≥35%) was statistically significantly bound up with shorter progress free survival and overall survival. The results of multivariate analysis showed that Ki-67 index (P = 0.001) and ovarian preservation (P = 0.040) were independent prognostic factors of progress free survival.ConclusionsA Ki-67 index cut-off of 35% was optimal for predicting recurrent endometrial stromal sarcoma. Ki-67 index may be a useful prognostic marker in endometrial stromal sarcoma.
first_indexed 2024-12-20T10:28:15Z
format Article
id doaj.art-dcd72f678e94496ba6646a9dc85bfe40
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-20T10:28:15Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-dcd72f678e94496ba6646a9dc85bfe402022-12-21T19:43:47ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-01-01810.3389/fmed.2021.823505823505Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal SarcomaYu Meng0Quan Quan1Fenfen Zhang2Yao Liu3Siling Ren4Xiaoling Mu5Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Obstetrics and Gynecology, Chengdu First People Hospital, Chengdu, ChinaDepartment of Obstetrics, Chongqing Fuling District Maternal and Child Health Care, Chongqing, ChinaDepartment of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaObjectiveThe Ki-67 index is used to evaluate cell proliferation activity, which is related to tumor progression, metastasis, and prognosis. We aimed to explore the prognostic value of Ki-67 index in endometrial stromal sarcoma and to explore the optimal cut-off value of Ki-67 index for predicting recurrent endometrial stromal sarcoma.MethodsA total of 82 patients with endometrial stromal sarcoma who were treated in our hospital were collected. Clinicopathological data of these patients were retrospectively analyzed. Ki-67 index was detected by the immunohistochemical method. Receiver operating characteristic curve and the Youden index were performed to determine the optimal cut-off value of Ki-67 index for predicting recurrent endometrial stromal sarcoma. The Cox regression was performed to analyze risk factors affecting prognosis of endometrial stromal sarcoma. The Kaplan–Meier method and Log-rank test were performed to analyze the survival of patients.ResultsThe optimal cut-off value of Ki-67 index for predicting recurrent endometrial stromal sarcoma was 35%. The results of univariate analysis showed that high Ki-67 index (≥35%) was statistically significantly bound up with shorter progress free survival and overall survival. The results of multivariate analysis showed that Ki-67 index (P = 0.001) and ovarian preservation (P = 0.040) were independent prognostic factors of progress free survival.ConclusionsA Ki-67 index cut-off of 35% was optimal for predicting recurrent endometrial stromal sarcoma. Ki-67 index may be a useful prognostic marker in endometrial stromal sarcoma.https://www.frontiersin.org/articles/10.3389/fmed.2021.823505/fullendometrial stromal sarcomarecurrencepredictprognosisKi-67
spellingShingle Yu Meng
Quan Quan
Fenfen Zhang
Yao Liu
Siling Ren
Xiaoling Mu
Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma
Frontiers in Medicine
endometrial stromal sarcoma
recurrence
predict
prognosis
Ki-67
title Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma
title_full Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma
title_fullStr Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma
title_full_unstemmed Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma
title_short Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma
title_sort prognostic value of ki 67 index in patients with endometrial stromal sarcoma
topic endometrial stromal sarcoma
recurrence
predict
prognosis
Ki-67
url https://www.frontiersin.org/articles/10.3389/fmed.2021.823505/full
work_keys_str_mv AT yumeng prognosticvalueofki67indexinpatientswithendometrialstromalsarcoma
AT quanquan prognosticvalueofki67indexinpatientswithendometrialstromalsarcoma
AT fenfenzhang prognosticvalueofki67indexinpatientswithendometrialstromalsarcoma
AT yaoliu prognosticvalueofki67indexinpatientswithendometrialstromalsarcoma
AT silingren prognosticvalueofki67indexinpatientswithendometrialstromalsarcoma
AT xiaolingmu prognosticvalueofki67indexinpatientswithendometrialstromalsarcoma